Wire · opportunities
FDA Approves OTC 12-Hour Cold and Fever Medication
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 28 August 2026 · Fusion42 review
The FDA approved Mucinex 12hr Cold & Fever Multi-Symptom, the first OTC cold and flu medication innovation in 14 years, featuring a triple-action formula providing up to 12 hours of relief. This approval follows over a decade of clinical research aimed at extending symptom management for cold and flu sufferers in the US.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You need to rethink your cold and flu product timelines as US regulatory barriers around OTC innovation just eased. This approval opens new opportunities for longer-lasting symptom relief formulations to compete in a US market starved for fresh options.
◆ Coverage
1 source · 8 Aug 2026
◆ Related on Wire
◆ Topics